FDA product code MXD: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)
MXD is the FDA product code for recorder, event, implantable cardiac, (with arrhythmia detection). It is a Class II device, regulated under 21 CFR 870.1025 and reviewed by the Cardiovascular panel. FDA has cleared 34 510(k) submissions under MXD, 14 in the last five years, from 6 different applicants. The average 510(k) review took 86 days (median 65); 38 days on average over the last three years. FDA has posted 10 recalls for MXD devices, 8 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) |
| Device class | Class II |
| Regulation | 21 CFR 870.1025 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for MXD
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 4 | 66 |
| 2019 | 1 | 122 |
| 2020 | 4 | 126 |
| 2021 | 4 | 62 |
| 2022 | 2 | 40 |
| 2023 | 6 | 73 |
| 2024 | 1 | 15 |
| 2025 | 3 | 71 |
| 2026 | 2 | 29 |
Compare with all 510(k) review times · Search every MXD clearance
Top MXD applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Medtronic, Inc. | 17 | 2026-08-28 |
| Biotronik, Inc. | 11 | 2026-05-01 |
| Boston Scientific Corporation | 3 | 2025-09-12 |
| ABBOTT MEDICAL | 1 | 2025-12-18 |
| Abbott | 1 | 2025-09-17 |
1 more applicants have MXD clearances. See the full list in Caduvo.
Most recent MXD clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K262735 | Medtronic, Inc. | LINQ II Insertable Cardiac Monitor (ICM) (LNQ22) | 2026-08-28 | 28 |
| K261074 | Biotronik, Inc. | BIOMONITOR IV (471155) | 2026-05-01 | 30 |
| K253516 | ABBOTT MEDICAL | Assert-IQ (DM5100) | 2025-12-18 | 36 |
| K251221 | Abbott | Assert-IQ (DM5000); Assert-IQ (DM5300); Assert-IQ (DM5500); Merlin.net (MN7000) | 2025-09-17 | 149 |
| K252593 | Boston Scientific Corporation | LUX-Dx II Insertable Cardiac Monitor (M302); LUX-Dx II+ Insertable Cardiac Monitor (M312) | 2025-09-12 | 28 |
Recalls for MXD devices
10 product recalls in 7 recall events; 8 initiated in the last five years and 9 still open. Most recent: 2026-08-06.
| Year | Recalls |
|---|---|
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 5 |
Frequently asked questions
What is FDA product code MXD?
MXD is the FDA product code for recorder, event, implantable cardiac, (with arrhythmia detection). It is a Class II device, regulated under 21 CFR 870.1025 and reviewed by the Cardiovascular panel.
What device class is MXD?
Class II, regulation 21 CFR 870.1025. Typical premarket route: 510(k).
How long does a 510(k) take for product code MXD?
Across 34 cleared submissions the average was 86 days from receipt to decision (median 65).
Which companies have the most MXD clearances?
Medtronic, Inc. (17); Biotronik, Inc. (11); Boston Scientific Corporation (3); ABBOTT MEDICAL (1); Abbott (1).
Have MXD devices been recalled?
Yes: 10 product recalls across 7 recall events; the most recent began 2026-08-06.
Next steps
- Run an FDA pathway report with predicate devices for product code MXD
- Run a recall and safety report across every MXD manufacturer
- Watch product code MXD for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times